Torasemide transport by organic anion transporters contributes to hyperuricemia.
Hagos
Yohannes
Y
Abteilung Vegetative Physiologie und Pathophysiologie, Georg August Universität, Göttingen, Germany. hagos@physiol.med.uni-goettingen.de
Bahn
Andrew
A
Vormfelde
Stefan V
SV
Brockmöller
Jürgen
J
Burckhardt
Gerhard
G
D000818:Animals; D000959:Antihypertensive Agents / Q000493:pharmacokinetics*; D001189:Aryl Hydrocarbon Hydroxylases / Q000378:metabolism; D001692:Biological Transport; D065729:Cytochrome P-450 CYP2C9; D006801:Humans; D033461:Hyperuricemia / Q000378:metabolism*; D007700:Kinetics; D008956:Models, Chemical; D009865:Oocytes / Q000378:metabolism; D027361:Organic Anion Transporters / Q000378:metabolism*; D010100:Oxygen / Q000378:metabolism; D021381:Protein Transport; D013449:Sulfonamides / Q000493:pharmacokinetics*; D000077786:Torsemide; D014162:Transfection; D014982:Xenopus laevis
D000959:Antihypertensive Agents; D027361:Organic Anion Transporters; D013449:Sulfonamides; C450260:CYP2C9 protein, human; D065729:Cytochrome P-450 CYP2C9; D001189:Aryl Hydrocarbon Hydroxylases; D010100:Oxygen; D000077786:Torsemide